Since ERK5 is activated by MEK5, we tried to examine the effect of ERK5 activation on c-Myc expression by introducing dominant-negative MEK5A or constitute active MEK5D into human colon cancer cells DLD-1 [22]. The gene discussed is MAP2K5; the disease is malignant colon neoplasm.